Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement

Rachel Sagar, Graça Almeida-Porada, Karin Blakemore, Jerry K.Y. Chan, Mahesh Choolani, Cecilia Götherström, Agnes Jaulent, Tippi C. MacKenzie, Citra Mattar, Christopher D. Porada, William H. Peranteau, Holm Schneider, Steven W. Shaw, Simon N. Waddington, Magnus Westgren, Anna L. David

Open source

DOI
10.1016/j.ymthe.2020.10.012
Published
2020-11
Container
Molecular Therapy
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ymthe.2020.10.012,
  title = {Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement},
  author = {Rachel Sagar and Graça Almeida-Porada and Karin Blakemore and Jerry K.Y. Chan and Mahesh Choolani and Cecilia Götherström and Agnes Jaulent and Tippi C. MacKenzie and Citra Mattar and Christopher D. Porada and William H. Peranteau and Holm Schneider and Steven W. Shaw and Simon N. Waddington and Magnus Westgren and Anna L. David},
  year = {2020},
  journal = {Molecular Therapy},
  doi = {10.1016/j.ymthe.2020.10.012},
  url = {https://doi.org/10.1016/j.ymthe.2020.10.012}
}

RIS

TY  - JOUR
TI  - Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement
AU  - Rachel Sagar
AU  - Graça Almeida-Porada
AU  - Karin Blakemore
AU  - Jerry K.Y. Chan
AU  - Mahesh Choolani
AU  - Cecilia Götherström
AU  - Agnes Jaulent
AU  - Tippi C. MacKenzie
AU  - Citra Mattar
AU  - Christopher D. Porada
AU  - William H. Peranteau
AU  - Holm Schneider
AU  - Steven W. Shaw
AU  - Simon N. Waddington
AU  - Magnus Westgren
AU  - Anna L. David
PY  - 2020
JO  - Molecular Therapy
DO  - 10.1016/j.ymthe.2020.10.012
UR  - https://doi.org/10.1016/j.ymthe.2020.10.012
ER  - 

APA

Sagar, R., Almeida-Porada, G., Blakemore, K., Chan, J. K., Choolani, M., Götherström, C., Jaulent, A., MacKenzie, T. C., Mattar, C., Porada, C. D., Peranteau, W. H., Schneider, H., Shaw, S. W., Waddington, S. N., Westgren, M., & David, A. L. (2020). Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2020.10.012

Source records